Please assess the completion status of the following clinical trial:

Trial Title: S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically or cytologically confirmed stage IIIB non-small cell lung cancer~  * Adenocarcinoma~ * Large cell carcinoma~ * Squamous cell carcinoma~* Pathologically or radiographically documented positive N3 nodes~  * No positive supraclavicular or scalene lymph nodes with disease extending into the cervical region OR~* T4 tumor invading any of the following:~  * Mediastinum~ * Heart~ * Great vessels~ * Trachea~ * Esophagus~ * Vertebral body~ * Carina~* No brain, contralateral chest, liver, or adrenal metastases~* No more than 1 parenchymal lesion~* No malignant pleural effusions unless they are only visible on CT scan or deemed too small to tap~* No pericardial effusions~* Measurable disease~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* Zubrod 0-2~Life expectancy:~* Not specified~Hematopoietic:~* Absolute neutrophil count at least 1,500/mm\^3~* Platelet count at least 100,000/mm\^3~Hepatic:~* Not specified~Renal:~* Creatinine clearance at least 50 mL/min~Pulmonary:~* One of the following:~  * FEV1 at least 2.0 L~ * Predicted FEV1 of contralateral lung greater than 800 mL~ * Predicted post-treatment FEV1 at least 1.0 L~Other:~* No other prior malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer or carcinoma in situ of the cervix~* Not pregnant or nursing~* Fertile patients must use effective contraception~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* No concurrent growth factors during induction chemoradiotherapy~Chemotherapy:~* No prior chemotherapy for lung cancer~Endocrine therapy:~* Not specified~Radiotherapy:~* No prior radiotherapy for lung cancer~Surgery:~* No prior surgical resection of lung cancer~* Prior exploratory thoracotomy, mediastinoscopy, excisional biopsy, or similar surgery for determining diagnosis, stage, or potential resectability allowed

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- chemo/RT followed by consolidation chemo (Type: EXPERIMENTAL): cisplatin docetaxel radiation therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).